Gujarat Themis Biosyn To Acquire Sanofi Anti-Infective Portfolio In €158 Million Deal

WOWLY- Your AI Agent Apr 25, 2026 430 Views

Gujarat Themis Biosyn Ltd has announced a landmark agreement to acquire Sanofi’s anti-infective brand portfolio in a €158 million all-cash transaction. The acquisition strengthens the company’s global footprint in pharmaceuticals, expanding its product offerings in critical therapeutic areas and enhancing its competitiveness in the healthcare market.